123 related articles for article (PubMed ID: 16185870)
1. How do we measure a residual tumor size in histopathology (the gold standard) after neoadjuvant chemotherapy?
Apple SK; Suthar F
Breast; 2006 Jun; 15(3):370-6. PubMed ID: 16185870
[TBL] [Abstract][Full Text] [Related]
2. Computer-aided detection applied to breast MRI: assessment of CAD-generated enhancement and tumor sizes in breast cancers before and after neoadjuvant chemotherapy.
Demartini WB; Lehman CD; Peacock S; Russell MT
Acad Radiol; 2005 Jul; 12(7):806-14. PubMed ID: 16039534
[TBL] [Abstract][Full Text] [Related]
3. Optimal assessment of residual disease after neo-adjuvant therapy for locally advanced and inflammatory breast cancer--clinical examination, mammography, or magnetic resonance imaging?
Wright FC; Zubovits J; Gardner S; Fitzgerald B; Clemons M; Quan ML; Causer P
J Surg Oncol; 2010 Jun; 101(7):604-10. PubMed ID: 20461768
[TBL] [Abstract][Full Text] [Related]
4. Pure and predominantly pure intralymphatic breast carcinoma after neoadjuvant chemotherapy: an unusual and adverse pattern of residual disease.
Rabban JT; Glidden D; Kwan ML; Chen YY
Am J Surg Pathol; 2009 Feb; 33(2):256-63. PubMed ID: 18936689
[TBL] [Abstract][Full Text] [Related]
5. MRI-model to guide the surgical treatment in breast cancer patients after neoadjuvant chemotherapy.
Straver ME; Loo CE; Rutgers EJ; Oldenburg HS; Wesseling J; Vrancken Peeters MJ; Gilhuijs KG
Ann Surg; 2010 Apr; 251(4):701-7. PubMed ID: 20224378
[TBL] [Abstract][Full Text] [Related]
6. Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy.
Partridge SC; Gibbs JE; Lu Y; Esserman LJ; Sudilovsky D; Hylton NM
AJR Am J Roentgenol; 2002 Nov; 179(5):1193-9. PubMed ID: 12388497
[TBL] [Abstract][Full Text] [Related]
7. [MRI evaluation of primary chemotherapy response in breast cancer].
Vénat-Bouvet L; Desfougères M; Aubard Y; Mollard J; Fermeaux V; Genet D; Labourey JL; Martin J; Lebrun-Ly V; Maubon A; Tubiana-Mathieu N
Bull Cancer; 2004 Sep; 91(9):721-8. PubMed ID: 15544998
[TBL] [Abstract][Full Text] [Related]
8. Residual specimen cellularity after neoadjuvant chemotherapy for breast cancer.
Peintinger F; Kuerer HM; McGuire SE; Bassett R; Pusztai L; Symmans WF
Br J Surg; 2008 Apr; 95(4):433-7. PubMed ID: 18161887
[TBL] [Abstract][Full Text] [Related]
9. Combined use of MRI and PET to monitor response and assess residual disease for locally advanced breast cancer treated with neoadjuvant chemotherapy.
Chen X; Moore MO; Lehman CD; Mankoff DA; Lawton TJ; Peacock S; Schubert EK; Livingston RB
Acad Radiol; 2004 Oct; 11(10):1115-24. PubMed ID: 15530804
[TBL] [Abstract][Full Text] [Related]
10. Comparison of risk of local-regional recurrence after mastectomy or breast conservation therapy for patients treated with neoadjuvant chemotherapy and radiation stratified according to a prognostic index score.
Huang EH; Strom EA; Perkins GH; Oh JL; Chen AM; Meric-Bernstam F; Hunt KK; Sahin AA; Hortobagyi GN; Buchholz TA
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):352-7. PubMed ID: 16887286
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy.
Rosen EL; Blackwell KL; Baker JA; Soo MS; Bentley RC; Yu D; Samulski TV; Dewhirst MW
AJR Am J Roentgenol; 2003 Nov; 181(5):1275-82. PubMed ID: 14573420
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of nomograms for predicting residual tumor size and the probability of successful conservative surgery with neoadjuvant chemotherapy for breast cancer.
Rouzier R; Pusztai L; Garbay JR; Delaloge S; Hunt KK; Hortobagyi GN; Berry D; Kuerer HM
Cancer; 2006 Oct; 107(7):1459-66. PubMed ID: 16948128
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging evaluation of residual tumors in breast cancer after neoadjuvant chemotherapy: surgical implications.
Zhou J; Li G; Sheng F; Qiao P; Zhang H; Xing X
Acta Radiol; 2016 May; 57(5):529-37. PubMed ID: 26231950
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of MRI for estimating residual tumor size after neoadjuvant chemotherapy in locally advanced breast cancer: relation to response patterns on MRI.
Kim HJ; Im YH; Han BK; Choi N; Lee J; Kim JH; Choi YL; Ahn JS; Nam SJ; Park YS; Choe YH; Ko YH; Yang JH
Acta Oncol; 2007; 46(7):996-1003. PubMed ID: 17851879
[TBL] [Abstract][Full Text] [Related]
15. Is there concordance of invasive breast cancer pathologic tumor size with magnetic resonance imaging?
Grimsby GM; Gray R; Dueck A; Carpenter S; Stucky CC; Aspey H; Giurescu ME; Pockaj B
Am J Surg; 2009 Oct; 198(4):500-4. PubMed ID: 19800455
[TBL] [Abstract][Full Text] [Related]
16. MR imaging for assessment of breast cancer response to neoadjuvant chemotherapy.
Hylton N
Magn Reson Imaging Clin N Am; 2006 Aug; 14(3):383-9, vii. PubMed ID: 17098179
[TBL] [Abstract][Full Text] [Related]
17. Recurrence rates after DCE-MRI image guided planning for breast-conserving surgery following neoadjuvant chemotherapy for locally advanced breast cancer patients.
Garimella V; Qutob O; Fox JN; Long ED; Chaturvedi A; Turnbull LW; Drew PJ
Eur J Surg Oncol; 2007 Mar; 33(2):157-61. PubMed ID: 17085007
[TBL] [Abstract][Full Text] [Related]
18. [Pathological manifestation and feasibility of conservative breast surgery after effective neoadjuvant chemotherapy for breast cancer].
Liu CP; Shi L; Li Z
Zhonghua Wai Ke Za Zhi; 2008 Sep; 46(18):1394-6. PubMed ID: 19094510
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of preoperative multidetector-row computed tomography in evaluating the extent of invasive lobular carcinoma in patients with or without neoadjuvant chemotherapy.
Shien T; Akashi-Tanaka S; Yoshida M; Hojo T; Iwamoto E; Miyagawa K; Kinoshita T
Breast Cancer; 2009; 16(1):30-6. PubMed ID: 18360805
[TBL] [Abstract][Full Text] [Related]
20. Dynamic enhanced MRI predicts chemosensitivity in breast cancer patients.
Nagashima T; Sakakibara M; Nakamura R; Arai M; Kadowaki M; Kazama T; Nakatani Y; Koda K; Miyazaki M
Eur J Radiol; 2006 Nov; 60(2):270-4. PubMed ID: 16926079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
